The Robert H. Lurie Comprehensive Cancer Center: Structural Biology

Project: Research project

Description

DESCRIPTION (provided by applicant): The Robert H. Lurie Comprehensive Cancer Center of Northwestern University isan NCI-designated, university-based, matrix cancer center conducting a broadrange of multidisciplinary clinical, laboratory and population scienceresearch. The Cancer Center integrates the expertise and resources of theMedical School (Chicago Campus) and its five affiliated hospitals along withthose of departments located on the University?s Evanston Campus. Establishedin 1974, the Cancer Center functions as a full organizational unit with thestatus of a department of the Medical School. Since its inception, the CancerCenter has been dedicated to the process of discovery, advancing medicalknowledge and providing compassionate, state-of-the-art cancer care, asreflected in the following goals: 1. To conduct and support cancer researchand to integrate cancer-related research throughout the University 2. Tocoordinate and integrate cancer-related activities of the University includingcommunity outreach initiatives 3. To develop and conduct cancer educationprograms 4. To promote and participate in state-of-the-art care of cancerpatients at the affiliated hospitals of the McGaw Medical Center ofNorthwestern University, and 5. To develop and implement initiatives in cancerprevention and control research 6. These goals are accomplished through theactivities of 10 established programs and 13 shared resources. Programs:Viral Oncogenesis, Tumor Invasion, Metastasis, & Angiogenesis, HormoneAction/Signal Transduction in Cancer, Cancer Genes and Molecular Regulation,Breast Cancer, Prostate Cancer, Hematologic Malignancies, Pediatric Oncology,Cancer Prevention, and Cancer Control. Shared Resources: Media Prep, FlowCytometry, Cell Imaging, Transgenic Core, Pathology Core, Biotechnology, KeckBiophysics, Monoclonal Antibodies, Immunoassay, MR Research, StructuralBiology, Biostatistics Core, and Clinical Research Office.
StatusFinished
Effective start/end date8/1/017/31/07

Funding

  • National Cancer Institute (3 P30 CA060553-13S3)

Fingerprint

Neoplasms
Research
Prostatic Neoplasms
Biostatistics
Neoplasm Genes
Hematologic Neoplasms
Biotechnology
Medical Schools
Immunoassay
Signal Transduction
Carcinogenesis
Monoclonal Antibodies
Pediatrics
Pathology
Breast Neoplasms
Neoplasm Metastasis
Population